#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rosai-Dorfman syndrome Oesophageal adenocarcinoma Undifferentiated sarcoma Skin angiosarcoma Paget's disease of the vulva Neovascular age-related macular degeneration Haematological malignancy Mitochondrial myopathy Kawasaki's disease Liposarcoma Colon cancer Spinal cord injury Amyotrophic lateral sclerosis Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Frontotemporal dementia More trials…

    Learn about Rare Diseases

    Combined immunodeficiency – Life with Disease Soft tissue sarcoma – Trials in Disease Optic glioma – Trials in Disease Breast angiosarcoma – Basic Information Behcet’s syndrome – Treatment Atypical haemolytic uraemic syndrome – Trials in Disease Mucopolysaccharidosis – Diagnostics Chondrosarcoma – Treatment Haemophilia B with anti factor IX – Trials in Disease Factor VIII deficiency – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rgx-202 AZD0022 ACETYLCARNITINE HYDROCHLORIDE Glutenin Sugammadex Vortioxetine Mirabegron Futibatinib Phenazone Batoprotafib Luspatercept Inclisiran Sodium Clonazepam Bi 1839100 Chlorhexidine Gluconate Fosfomycin Trometamol Trometamol Tezepelumab Seladelpar Flecainide Acetate More therapies…

    Learn about Your Condition

    Merycism Psychotic behaviour Peritoneal neoplasm Thrombocytosis Hypochondroplasia Neuroendocrine carcinoma Liposarcoma metastatic Psoriatic arthropathy Choreoathetosis Progressive supranuclear palsy Prinzmetal angina Thrombotic microangiopathy Lung adenocarcinoma stage IV Seizure Nasopharyngeal cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mfdvzt Zfbnbpor Kdomt 2rh Dsmyqmctv 4petq Hatqkin

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Long-Term Safety of Dazukibart in Patients with Idiopathic Inflammatory Myopathies, Including Dermatomyositis and Polymyositis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Betamethasone
    • CHLOROQUINE PHOSPHATE
    • Dazukibart
    Bulgaria Hungary Italy Poland Spain Sweden

  • Study of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment

    Recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Risankizumab
    • Sonelokimab
    Bulgaria Czechia France Germany Hungary Poland +1

  • Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Elacestrant
    • Anastrozole
    • Exemestane
    Austria Belgium Czechia Denmark Finland France +9

  • Study of Zilovertamab Vedotin and Drug Combination for Untreated Diffuse Large B-Cell Lymphoma Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    Belgium Denmark France Greece Hungary Italy +5

  • Study of Pozelimab and Cemdisiran for Adults with Geographic Atrophy from Age-Related Macular Degeneration

    Recruiting

    3 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    • Age-related macular degeneration
    Investigated Drugs:
    • Cemdisiran
    • Pozelimab
    Austria France Germany Hungary Italy Poland +1

  • Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

    Recruiting

    3 1
    Investigated Diseases:
    • Acute respiratory failure
    Investigated Drugs:
    • Tozorakimab
    Belgium Bulgaria Czechia Denmark France Germany +8

  • Study comparing Rilvegostomig plus chemotherapy versus Pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Infliximab
    Belgium France Germany Hungary Italy The Netherlands +2

  • Study on the Effect of Caffeine Citrate for Patients with Extubation Failure and Bronchopulmonary Dysplasia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Infantile apnoea
    • Neonatal respiratory failure
    • Premature baby
    Investigated Drugs:
    • Caffeine Citrate
    Hungary

  • Study on the Effectiveness and Safety of Ianalumab for Patients with Diffuse Cutaneous Systemic Sclerosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • Emtricitabine
    Austria Belgium France Germany Greece Hungary +4

  • Study on Clemizole Hydrochloride for Children and Adults with Dravet Syndrome

    Recruiting

    3 1
    Investigated Diseases:
    • Severe myoclonic epilepsy of infancy
    Investigated Drugs:
    • Clemizole Hydrochloride
    Hungary Poland Spain
Previous Page
1 … 10 11 12 13 14 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!